MetLife integrovala pojištění domácích mazlíčků do ChatGPT, kde zákazníci získají personalizované nabídky a mohou si pojištění sjednat na webových stránkách MetLife.
Key Takeaways MetLife integrates pet insurance with ChatGPT, enabling conversational applications and personalized quotes.Rising veterinary costs drive demand, with 70% of pet owners delaying or skipping treatment due to expenses.MET's ChatGPT integration could boost policy sales and distribution efficiency, but claims costs remain key. MetLife, Inc. (MET - Free Report) is expanding its digital distribution strategy by integrating its pet insurance portal with ChatGPT. The insurer is the first major pet insurance provider to offer conversational applications and binding quotes through the platform. Customers can explore coverage, answer questions about their pets and obtain personalized quotes before completing purchases on MetLife’s website.
The launch comes amid rising veterinary expenses and low pet insurance penetration. MetLife’s data shows that one-third of employees worry about affording pet care, yet fewer than 10% have pet insurance. Meanwhile, 70% of pet owners have delayed or skipped veterinary treatment due to costs, with more than one-third reporting worsening pet conditions. These figures highlight growing demand for pet insurance coverage.
For MetLife, the strategic value lies in bringing insurance applications and quotes into a conversational platform. Simplifying the initial shopping process could help the insurer reach digitally engaged consumers and encourage more prospective customers to explore coverage. This provides another distribution channel without requiring a comparable expansion of traditional sales infrastructure.
The integration could support premium growth if increased customer engagement translates into additional policy sales. A streamlined application process may also improve distribution efficiency. However, higher policy volumes alone would not guarantee stronger profitability, as claims costs, pricing adequacy and customer retention will remain important determinants of underwriting performance.
MetLife has not disclosed financial targets or expected revenue contributions from the integration, leaving its near-term earnings impact uncertain. Its success will depend on whether the convenience of AI-assisted shopping translates into sustained policy sales. Nevertheless, the initiative expands its digital distribution capabilities and offers a potential long-term growth avenue.
How Are MetLife's Competitors Faring?A couple of MET's competitors in the pet insurance market are Chubb Limited (CB - Free Report) and The Progressive Corporation (PGR - Free Report) .
Chubb's Healthy Paws serves more than half a million pet owners, offering customizable insurance coverage, 24/7 virtual veterinary consultations and streamlined claims processing, with most claims processed within two days. These capabilities strengthen Chubb's competitive position by combining comprehensive pet insurance offerings with convenient digital services and efficient claims handling.
Progressive expanded its pet insurance business in January 2026 with a directly underwritten offering administered by Companion Protect, alongside its existing Pets Best arrangement. The new program offers customizable accident and illness coverage with optional wellness benefits, expanding PGR's product portfolio and strengthening its ability to capture growing demand for veterinary expense protection.
Společnost MetLife vyplatí 8. prosince čtvrtletní dividendu ve výši 0,5925 USD na akcii akcionářům evidovaným k 3. listopadu; v přepočtu na celý rok činí dividenda 2,37 USD.
MetLife, Inc. (NYSE:MET – Get Free Report) announced a quarterly dividend on Tuesday, October 6th. Shareholders of record on Tuesday, November 3rd will be paid a dividend of $0.5925 per share by the financial services provider on Tuesday, December 8th. This represents a $2.37 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, November 3rd.
MetLife has increased its dividend by an average of 0.0%annually over the last three years and has raised its dividend annually for the last 12 consecutive years. MetLife has a payout ratio of 22.9% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect MetLife to earn $10.70 per share next year, which means the company should continue to be able to cover its $2.37 annual dividend with an expected future payout ratio of 22.1%.
MetLife Stock Performance Shares of MET stock opened at $97.22 on Wednesday. The company has a market capitalization of $62.56 billion, a P/E ratio of 18.63, a price-to-earnings-growth ratio of 0.92 and a beta of 0.78. MetLife has a 52 week low of $67.33 and a 52 week high of $100.93. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.20 and a current ratio of 0.20. The company’s 50 day moving average price is $96.53 and its two-hundred day moving average price is $87.17.
MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 EPS for the quarter, topping analysts’ consensus estimates of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The business had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same period last year, the business posted $2.02 earnings per share. The firm’s quarterly revenue was up 10.5% on a year-over-year basis. On average, analysts expect that MetLife will post 9.85 earnings per share for the current fiscal year. Analysts Set New Price Targets A number of research firms recently issued reports on MET. Mizuho increased their price objective on MetLife from $95.00 to $102.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of MetLife in a research note on Friday, September 11th. Wells Fargo & Company boosted their price objective on shares of MetLife from $101.00 to $109.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 19th. TD Cowen increased their target price on shares of MetLife from $105.00 to $110.00 and gave the stock a “buy” rating in a report on Monday. Finally, Morgan Stanley lifted their price target on shares of MetLife from $103.00 to $111.00 and gave the company an “overweight” rating in a research note on Monday, August 24th. Twelve investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $105.08.
View Our Latest Report on MET
About MetLife (Get Free Report)
MetLife, Inc is a global financial services company that provides insurance, employee benefits and retirement solutions. Its products and services include life insurance, dental and vision coverage, disability insurance, accident and health benefits, annuities, and savings and retirement products.
The company serves individuals, employers and institutions through group benefits, workplace solutions and individual insurance offerings. MetLife also provides investment and retirement services designed to help employers and employees prepare for long-term financial needs.
Founded in 1868, MetLife is headquartered in New York City and operates through businesses in the United States and international markets, including regions across Latin America, Asia and Europe.
See Also Five stocks we like better than MetLife Allient’s Data Center and Defense Momentum Is Raising the Stakes Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AI Lamb Weston’s Turnaround Is Starting to Look Real These 3 Stocks Got the Most Love From Analysts in September
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
Argent Capital Management LLC purchased a new stake in MetLife, Inc. (NYSE:MET – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 121,303 shares of the financial services provider’s stock, valued at approximately $11,422,000.
Several other hedge funds have also modified their holdings of the stock. BlackRock Inc. purchased a new position in MetLife during the second quarter worth approximately $4,381,692,000. Pzena Investment Management LLC purchased a new stake in MetLife during the second quarter valued at about $941,792,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of MetLife by 5.9% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,026,518 shares of the financial services provider’s stock worth $509,904,000 after purchasing an additional 336,794 shares during the period. Bank of America Corp DE acquired a new position in MetLife during the second quarter valued at approximately $455,424,000. Finally, Legal & General Group Plc acquired a new stake in shares of MetLife in the second quarter worth $326,904,000. 94.99% of the stock is owned by institutional investors and hedge funds.
MetLife Stock Up 2.1% NYSE:MET traded up $2.00 during trading hours on Monday, reaching $96.43. The company’s stock had a trading volume of 1,059,373 shares, compared to its average volume of 3,631,547. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. The company has a market cap of $62.05 billion, a price-to-earnings ratio of 18.46, a price-to-earnings-growth ratio of 0.90 and a beta of 0.78. MetLife, Inc. has a one year low of $67.33 and a one year high of $100.93. The business’s 50-day moving average is $96.51 and its 200-day moving average is $86.78.
MetLife (NYSE:MET – Get Free Report) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, beating the consensus estimate of $2.30 by $0.13. The company had revenue of $13.52 billion for the quarter, compared to analyst estimates of $19.67 billion. MetLife had a return on equity of 23.39% and a net margin of 4.57%.The business’s revenue was up 10.5% compared to the same quarter last year. During the same period last year, the company earned $2.02 earnings per share. Equities research analysts predict that MetLife, Inc. will post 9.83 EPS for the current year. MetLife announced that its board has authorized a stock buyback plan on Wednesday, August 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board believes its shares are undervalued.
MetLife Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th were issued a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Tuesday, August 4th. MetLife’s dividend payout ratio is 45.40%.
Analysts Set New Price Targets Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. lifted their price target on shares of MetLife from $106.00 to $108.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 11th. Keefe, Bruyette & Woods increased their price target on MetLife from $105.00 to $108.00 and gave the company an “outperform” rating in a report on Tuesday, August 11th. Atlantic Securities set a $103.00 price objective on MetLife in a report on Wednesday, July 15th. Weiss Ratings reiterated a “buy (b)” rating on shares of MetLife in a research note on Friday, September 11th. Finally, UBS Group lifted their price target on MetLife from $102.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 8th. Twelve research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $104.69.
View Our Latest Analysis on MetLife
About MetLife (Free Report)
MetLife, Inc is a global financial services company that provides insurance, employee benefits and retirement solutions. Its products and services include life insurance, dental and vision coverage, disability insurance, accident and health benefits, annuities, and savings and retirement products.
The company serves individuals, employers and institutions through group benefits, workplace solutions and individual insurance offerings. MetLife also provides investment and retirement services designed to help employers and employees prepare for long-term financial needs.
Founded in 1868, MetLife is headquartered in New York City and operates through businesses in the United States and international markets, including regions across Latin America, Asia and Europe.
Read More Five stocks we like better than MetLife What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks Insiders Are Selling These 3 Stocks, Should You? Datadog’s Rally Has Insiders Selling—Can It Keep Climbing?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
MetLife ve 2. čtvrtletí 2026 zvýšila upravený zisk segmentu Group Benefits o 25 % na 503 mil. USD díky růstu objemu a lepšímu upisování. Pomohly i upravené PFOs, které vzrostly o 4 %.
Key Takeaways In Q2 2026, MET's Group Benefits earnings rose 25% year over year on volume growth and improved underwriting.Group Life's mortality ratio fell to 79% in Q2 2026, below the 83%-88% target range for 2026.MET's adjusted PFOs rose 4% year over year in Q2 2026, supported by steady demand across employee benefits. MetLife, Inc.’s (MET - Free Report) Group Benefits business is emerging as a key source of earnings momentum, supported by stronger underwriting and steady demand for employee benefits. In the second quarter of 2026, the segment’s adjusted earnings rose 25% year over year to $503 million. The gain reflected solid volume growth and improved life underwriting. Group Life’s mortality ratio was 79% in the second quarter, below MET’s 2026 target range of 83% to 88%.
The business is benefiting from its broad portfolio of employee benefits, including group life, dental, disability and voluntary products. MET’s scale in the U.S. group benefits market also provides a wide distribution network and opportunities to deepen relationships with employers and employees. These factors could support top-line growth as companies continue to prioritize benefits as part of their employee offerings. Adjusted premiums, fees and other revenues (PFOs), excluding participating contracts, rose 4% year over year in the second quarter of 2026.
Year to date, the unit’s sales increased 9%, with regional business up 11%, led by the under-1,000 employee market. Higher employee participation, solid persistency and rising demand for voluntary coverage are supporting the franchise. The non-medical health interest-adjusted benefit ratio also improved to 73.9% in the second quarter of 2026 from 74.8% a year ago.
However, some of the second-quarter mortality benefit may not persist. About two percentage points of favorability reflected prior-period development and lower-than-expected claim severity, factors expected to normalize in the second half. Steady sales, persistency and diversified product demand could help Group Benefits maintain momentum, though earnings growth may moderate if underwriting benefits ease.
How Are Competitors Faring?Some of MET’s competitors in the insurance space include The Hartford Insurance Group, Inc. (HIG - Free Report) and Aflac Incorporated (AFL - Free Report) .
The Hartford’s Employee Benefits business continues to expand, with fully insured ongoing premiums up 5% year over year in the second quarter of 2026. Fully insured ongoing sales jumped 31% year over year, supported by rising group disability and group life sales. However, a higher disability loss ratio weighed on HIG’s earnings.
Aflac’s U.S. business continues to benefit from demand for group voluntary benefits, network dental and vision products. Aflac U.S. sales increased 2.6% year over year in the second quarter of 2026, while net earned premiums rose 2.3%. However, higher benefits pressured pretax adjusted earnings, which declined 4.6% year over year.
MET’s Price Performance, Valuation & EstimatesIn the year-to-date period, MET’s shares have risen 22.6% compared with the industry’s growth of 2.5%.
Image Source: Zacks Investment Research
From a valuation standpoint, MET trades at a forward price-to-earnings ratio of 9.26, above the industry average of 8.95. MetLife carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MET’s 2026 earnings implies 10.8% growth from the year-ago period.
Image Source: Zacks Investment Research
MetLife currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Americké prodeje anuit ve 2. čtvrtletí 2026 vzrostly o 2 % na 121,2 mld. USD a za první pololetí dosáhly rekordu 228,7 mld. USD. Tahounem byly zejména produkty s ochranou jistiny a doživotním příjmem.
Key Takeaways U.S. annuity sales reached $121.2 billion in Q2 2026, and first-half sales reached a record $228.7 billion.PRU's retail annuity sales reached $3.6 billion, while net investment income rose 12% to $5.15 billion.MET's adjusted earnings rose 15% to $1.6 billion, while investment income increased 18% to $6.7 billion. The U.S. life insurance industry is benefiting from rising demand for products that help consumers protect their families, accumulate wealth and generate income during retirement. In this market, annuities are becoming increasingly important as an aging population approaches retirement and seeks reliable income sources that can last throughout their lifetimes.
The retirement opportunity extends beyond individual consumers. The shift from traditional defined-benefit pensions toward defined-contribution plans such as 401(k)s has placed greater responsibility on individuals to manage their retirement savings and protect against the risk of outliving their assets. At the same time, employers and pension plans are looking for ways to manage long-term retirement liabilities, creating opportunities for insurers through pension risk-transfer solutions.
U.S. annuity sales remained strong in the second quarter of 2026. According to LIMRA, total annuity sales reached $121.2 billion, up 2% year over year, marking the 11th consecutive quarter in which sales exceeded $100 billion. First-half sales reached a record $228.7 billion, up 1% from the prior-year period.
The strength is particularly notable across products offering a combination of market participation, principal protection and retirement income. Registered index-linked annuity sales increased 22% year over year to $23.3 billion in the second quarter, while traditional variable annuity sales jumped 24% to $17.7 billion. Income annuities also remained strong, with single-premium immediate annuity sales reaching a record $4.1 billion.
Several factors are supporting this demand. Higher interest rates can make guaranteed-income products more attractive, while strong equity markets have supported demand for variable and registered index-linked annuities. Higher yields can also benefit insurers over time as they reinvest new premiums and maturing assets at more attractive rates, potentially supporting investment income. The Fed recently raised interest rates by 25 basis points to a range of 3.75-4%, marking its first rate increase since 2023, after three consecutive cuts had lowered the range to 3.5-3.75% by December 2025.
The broader life insurance market is showing similar momentum. According to S&P Global Market Intelligence, U.S. life premiums increased 7.7% year over year in the second quarter of 2026, while individual life premiums rose 4.1%. Meanwhile, the individual life policy count also increased 8% according to LIMRA, indicating that demand is extending beyond annuities.
This combination of growing retirement needs, strong annuity demand, pension opportunities and a supportive yield environment is creating a favorable backdrop for insurers with established retirement and investment platforms. Prudential Financial, Inc. (PRU - Free Report) , Principal Financial Group, Inc. (PFG - Free Report) and MetLife, Inc. (MET - Free Report) stand out for their exposure to annuities, retirement solutions, pension businesses and investment income.
While market volatility, interest-rate changes, competition and investment risks remain important considerations, continued growth in retirement assets should provide a long-term opportunity for these insurers.
3 Life Insurers to WatchWith the help of the Zacks Stock Screener, we have selected three life insurance stocks with an impressive Value Score of A or B. PRU, PFG, and MET each carry a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Prudential Financial: Newark, NJ-based Prudential Financial is a diversified financial services company with significant exposure to retirement, annuities, life insurance, group insurance and asset management.
The company is particularly well positioned to benefit from the current annuity environment. In the second quarter of 2026, PRU generated $3.6 billion in retail annuity sales, supported by continued momentum in its registered index-linked annuity offerings. Its individual life business also recorded a 9% increase in sales to $237 million, driven primarily by variable accumulation products.
Prudential's broader earnings profile also benefits from investment income and asset management. Second-quarter net investment income rose 12% year over year to $5.15 billion, while assets under management increased 3.9% to $1.64 trillion. Strong retirement sales, growing investment income and continued demand for annuity products position PRU to benefit from the structural shift toward retirement-income solutions.
Estimates for PRU’s 2026 bottom line have risen 2.3% over the past 30 days and suggest a 1% increase from the year-ago reported number. Its expected long-term earnings growth is pegged at 4.6%.
Image Source: Zacks Investment Research
Principal Financial: Des Moines, IA-based Principal Financial Group provides retirement, investment management, insurance and employee-benefit solutions to individuals and businesses.
PFG has significant exposure to the retirement market through its Retirement and Income Solutions business. In the second quarter of 2026, transfer deposits reached $9 billion, up 30% year over year, while international pension assets under management reached $169 billion, up 18%. The company's diversified model also provides exposure to investment management and benefits. Principal Asset Management reported $30 billion in investment-management gross sales in the second quarter, while its Benefits and Protection segment reported an 11% increase in specialty-benefit sales. Life Insurance operating margin also improved 280 basis points.
PFG's combination of retirement solutions, pension assets, investment management and insurance gives it multiple ways to benefit as Americans accumulate retirement assets and structural shifts drive annuity demand.
Estimates for PFG’s 2026 bottom line have risen 0.5% over the past 30 days and suggest a 16.3% increase from the year-ago reported number. Its expected long-term earnings growth is pegged at 6.5%.
Image Source: Zacks Investment Research
MetLife: New York-based MetLife is a global provider of insurance, retirement and employee-benefit solutions. Its diversified business model gives the company exposure to both individual and institutional retirement needs.
MetLife's Retirement and Income Solutions segment generated $377 million in adjusted earnings in the second quarter of 2026. Overall adjusted earnings increased 15% year over year to $1.6 billion, while premiums, fees and other revenues increased 7% to $13.7 billion. The company is also benefiting from strong investment income. Net investment income increased 18% to $6.7 billion in the second quarter.
MetLife's institutional retirement capabilities also provide exposure to pension-related demand. Pension risk transfers allow companies to transfer certain pension obligations to insurers, allowing insurers to generate premium and investment income. The company's broad retirement, insurance and employee-benefits platform should allow it to benefit from growing demand for retirement solutions, while diversification across businesses helps reduce reliance on any single product category.
Estimates for MET’s 2026 bottom line have risen 0.6% over the past 30 days and suggest a 10.8% increase from the year-ago reported number. Its expected long-term earnings growth is pegged at 10.7%.
MetLife ve 2. čtvrtletí 2026 zvýšila upravený zisk o 15 % na 1,6 miliardy USD a celkové pojistné o 5,8 %. Silná likvidita podporuje odkupy akcií i dividendy.
Key Takeaways MetLife's adjusted earnings rose 15% and total premium increased 5.8% in Q2 2026.MET is using AI, asset management and its New Frontier strategy to support scalable growth.MetLife's strong liquidity supports shareholder returns through share repurchases and dividend payouts. MetLife, Inc. (MET - Free Report) benefits from its diversified product portfolio, strong corporate relationships and global footprint, which support steady business volumes and premium growth. Its cost-cutting efforts, cash generation ability, strategic acquisitions and partnerships further support growth. Over the past year, shares of MET have grown 17.9%, outperforming the industry’s 4.6% rise.
MetLife — with a market capitalization of $62 billion — primarily provides protection and investment products to a range of individual and institutional customers. Beyond offering individual annuities, insurance and investment products, the company also delivers group insurance, as well as retirement and savings products and services. Its forward P/E of 9.30X is higher than the industry average of 9.17X.
Courtesy of solid prospects, MET currently carries a Zacks Rank #3 (Hold) and a Value Score of A.
MET’s Growth DriversMetLife continues to benefit from broad-based growth across its businesses, supported by stronger sales, favorable underwriting trends and improving operating momentum. Adjusted earnings rose 15% year over year to $1.6 billion in the second quarter of 2026, while total premium increased 5.8%.
Group Benefits remains an important contributor, supported by customer additions, broader product adoption and digital capabilities. MET continues to see strong opportunities in retirement and international markets. RIS-adjusted PFOs, excluding pension risk transfers, increased 19%, led by U.K. longevity reinsurance and structured settlement sales, while newer solutions such as U.K. FundedRe are broadening the platform. In Asia, sales climbed 17% on a constant-currency basis, helped by product launches and equity market tailwinds in Korea, while Latin America and EMEA sales rose 9% and 15%, respectively, creating additional room for expansion.
MET is also using technology and asset management to support scalable growth. AI-driven productivity gains are helping the company manage expenses while improving customer service and creating opportunities to apply data across policies, claims and service interactions. Meanwhile, MetLife Investment Management is expanding its role as the company grows its asset base and captures benefits from the integration of PineBridge.
MET’s New Frontier strategy combines capital-light and capital-driven businesses, leveraging its retirement origination, investment and risk-management capabilities to pursue growth while creating additional assets for its investment management platform. This model supports earnings diversification and more efficient capital deployment. The company also has flexibility to pursue additional growth through reinsurance, third-party capital and targeted acquisitions. Reinsurance can help MetLife originate more retirement business while creating additional assets for its investment management platform. The company is also evaluating selective opportunities in asset management and Group Benefits that can add complementary capabilities without requiring transformational deals.
MetLife’s robust liquidity position, evidenced by $19.3 billion in cash and cash equivalents as of June 30, 2026, far exceeds its short-term debt of $460 million. This financial strength supports shareholder returns through share repurchases and dividend payouts. The company bought back common shares worth $700 million in the second quarter of 2026. It pursued additional repurchases of roughly $225 million in July 2026. Its dividend yield of 2.5% remains higher than the industry’s average of 2.4%.
Where Do Estimates for MET Stand?The Zacks Consensus Estimate for MetLife’s 2026 earnings is pegged at $9.76 per share, indicating a 10.5% year-over-year rise, which has been revised upward over the past seven days. Furthermore, the consensus mark for revenues is pegged at $78.7 billion for 2026. It beat earnings estimates in each of the past four quarters, with an average surprise of 5.7%.
MET Stock: Risks to WatchHowever, there are some factors that investors should keep a careful eye on.
MET’s variable investment income has been volatile in recent years and remained below target at $1.5 billion in 2025. The first quarter of 2026 produced $518 million of pre-tax variable investment income, but the second quarter fell to $231 million due to lower private equity returns, and real estate and other fund returns.
The company’s return on invested capital (ROIC) is 1.9%, below the industry average of 2%. This indicates relatively weaker capital efficiency and modest returns on its investments.
Better-Ranked PlayersSome better-ranked stocks in the insurance space are Hippo Holdings Inc. (HIPO - Free Report) , Slide Insurance Holdings, Inc. (SLDE - Free Report) and The Hanover Insurance Group, Inc. (THG - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Hippo Holdings’ current-year earnings is pinned at $2.46 per share and has witnessed two upward revisions in the past 60 days against no movement in the opposite direction. HIPO beat earnings estimates in each of the trailing four quarters, with the average surprise being 521.8%. The consensus estimate for current-year revenues is pegged at $581.9 million, implying 24.2% year-over-year growth.
The Zacks Consensus Estimate for Slide Insurance Holdings’ current-year earnings is pinned at $3.79 per share and has witnessed two upward revisions in the past 60 days against one movement in the opposite direction. SLDE beat earnings estimates in each of the trailing four quarters, with the average surprise being 36.9%. The consensus estimate for current-year revenues is pegged at $1.5 billion, implying 29.5% year-over-year growth.
The Zacks Consensus Estimate for Hanover Insurance Group’s current-year earnings is pinned at $20.17 per share and has witnessed two upward revisions in the past 30 days against no movement in the opposite direction. THG beat earnings estimates in each of the trailing four quarters, with the average surprise being 27.3%. The consensus estimate for current-year revenues is pegged at $7 billion, implying 4.6% year-over-year growth.
BlackRock Inc. purchased a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 51,786,925 shares of the financial services provider’s stock, valued at approximately $4,381,692,000. BlackRock Inc. owned approximately 8.05% of MetLife as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Strs Ohio increased its position in MetLife by 16.6% during the fourth quarter. Strs Ohio now owns 326,091 shares of the financial services provider’s stock worth $25,742,000 after buying an additional 46,469 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH raised its position in MetLife by 2.1% during the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 714,193 shares of the financial services provider’s stock worth $56,712,000 after buying an additional 14,515 shares during the last quarter. PFA Pension Forsikringsaktieselskab acquired a new stake in MetLife in the fourth quarter valued at about $81,494,000. Evergreen Capital Management LLC lifted its holdings in shares of MetLife by 195.8% in the 4th quarter. Evergreen Capital Management LLC now owns 33,260 shares of the financial services provider’s stock valued at $2,626,000 after buying an additional 22,016 shares during the period. Finally, Principal Financial Group Inc. boosted its position in shares of MetLife by 2.2% during the 4th quarter. Principal Financial Group Inc. now owns 622,789 shares of the financial services provider’s stock worth $49,163,000 after purchasing an additional 13,657 shares in the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In Several research firms have weighed in on MET. Piper Sandler upped their target price on MetLife from $86.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, June 24th. Weiss Ratings raised MetLife from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, June 15th. Atlantic Securities set a $103.00 target price on shares of MetLife in a report on Wednesday, July 15th. Barclays raised their price objective on MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Finally, Morgan Stanley raised their target price on shares of MetLife from $93.00 to $103.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $101.07.
Get Our Latest Analysis on MetLife Key MetLife News Here are the key news stories impacting MetLife this week:
Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO MetLife Trading Up 0.2% NYSE MET opened at $96.83 on Wednesday. The company has a market capitalization of $62.31 billion, a price-to-earnings ratio of 18.55, a price-to-earnings-growth ratio of 0.75 and a beta of 0.78. MetLife, Inc. has a 12 month low of $67.33 and a 12 month high of $100.93. The company’s fifty day moving average price is $92.00 and its two-hundred day moving average price is $81.86. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20.
MetLife (NYSE:MET – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share for the quarter, beating the consensus estimate of $2.30 by $0.13. The firm had revenue of $13.52 billion during the quarter, compared to analyst estimates of $19.67 billion. MetLife had a return on equity of 23.39% and a net margin of 4.57%.MetLife’s quarterly revenue was up 10.5% on a year-over-year basis. During the same period in the previous year, the company earned $2.02 earnings per share. As a group, research analysts predict that MetLife, Inc. will post 9.7 earnings per share for the current fiscal year.
MetLife declared that its board has approved a share buyback plan on Wednesday, August 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to buy up to 4.8% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.
MetLife Dividend Announcement The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be given a dividend of $0.5925 per share. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Tuesday, August 4th. MetLife’s dividend payout ratio is presently 45.40%.
About MetLife (Free Report)
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Further Reading Five stocks we like better than MetLife The AI Boom Is Turning This Cable Maker Into a Stock to Watch A Star Investor Just Trimmed Amazon—Here’s What It means Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
MetLife vykázala ve 2. čtvrtletí upravený zisk 1,6 miliardy USD, tedy 2,43 USD na akcii, meziročně o 15 % více. Upravený návrat na vlastní kapitál dosáhl 17 %.
Can Trupanion Turn Pet Insurance Loyalty Into Real Earnings?MetLife NYSE: MET reported second-quarter 2026 adjusted earnings of approximately $1.6 billion, or $2.43 per share, up 15% from a year earlier. Adjusted earnings per share increased 20%, while adjusted return on equity reached 17%, the top end of the company’s 15% to 17% annual target range.
Get MetLife alerts:
President and Chief Executive Officer Michel Khalaf said the results reflected the execution of MetLife’s “New Frontier” strategy, which combines capital-light businesses such as Group Benefits, international operations and asset management with capital-driven retirement and spread-based operations.
The “Duck Stock” Keeps Quietly Making Money for Shareholders“Adjusted earnings increased in every business segment compared with a year ago,” Khalaf said, citing strong underwriting, broad volume growth and continued capital returns to shareholders.
Capital Returns and Expense Management MetLife repurchased about $700 million of common shares during the quarter and returned more than $2.4 billion to shareholders through July through buybacks and common dividends. The company also announced a new $3 billion share repurchase authorization.
These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?Holding-company cash and liquid assets totaled $3.4 billion at June 30, within MetLife’s stated target buffer of $3 billion to $4 billion. Chief Financial Officer and Head of MetLife Investment Management John McCallion said the company returned approximately $1.1 billion to shareholders in the second quarter, including the share repurchases, and bought an additional roughly $225 million of shares in July.
The direct expense ratio was 12.1% in the quarter, compared with 11.7% in the year-ago quarter and for full-year 2025. The ratio included an approximately 50-basis-point impact from the addition of PineBridge Investments, which has a structurally higher expense profile. Management said it remains on track to beat its 12.1% full-year 2026 target through expense discipline and productivity initiatives.
Khalaf said artificial intelligence is becoming a structural advantage for the company because of the volume of policies, customer interactions and claims MetLife handles. He said the company monitors AI-related investment and usage costs under the same return standards applied to other investments and expenses.
Group Benefits Leads Segment Growth Group Benefits generated adjusted earnings of $503 million, up 25% year over year, supported by favorable life underwriting and volume growth. The group life mortality ratio was 79%, better than the company’s 2026 target range of 83% to 88%, reflecting improved mortality trends among the working-age population.
Ramy Tadros, president of MetLife’s U.S. business, said the quarter included about two points of mortality favorability from prior-period development and lower-than-expected claim severity. He said the company expects those factors to normalize during the remainder of the year, with early indications evident in July results.
Tadros said any longer-term normalization of Group Life margins would occur gradually because the business has a three- to five-year renewal cycle. Year-to-date Group Benefits sales rose 9%, including an 11% increase in regional business. Adjusted premiums, fees and other revenues increased 4% excluding participating contracts.
Non-Medical Health’s interest-adjusted benefit ratio was 73.9%, within its 70% to 75% annual target range and 190 basis points better sequentially. Tadros said paid family and medical leave claims followed the anticipated pattern of higher claims early in a program’s rollout before moderating. He also cited favorable disability results, driven by experience and investments in data analytics and AI intended to improve recoveries.
Retirement, International Operations and Asset Management Retirement & Income Solutions, or RIS, recorded adjusted earnings of $377 million, up 2% from the prior year. Adjusted premiums, fees and other revenues excluding pension risk transfers increased 19%, led by U.K. longevity reinsurance and structured settlement sales.
RIS reported a total investment spread of 97 basis points, below management’s 100- to 120-basis-point guidance range because of weaker private-equity returns in variable investment income. Core spread excluding variable investment income was 100 basis points, up 5 basis points sequentially. McCallion said MetLife expects its core RIS spread to remain within a 95- to 100-basis-point range and estimated third-quarter results could be near the midpoint because of real estate income seasonality.
Management described the U.S. pension risk transfer market as lighter in the first half, particularly for jumbo transactions, but said it sees a stronger opportunity pipeline for the second half. Tadros said MetLife sold nearly $14 billion of pension risk transfers in 2025, including $12 billion in the fourth quarter, illustrating the market’s uneven timing. He added that MetLife wrote more than $1 billion of U.K. funded reinsurance year to date.
Asia adjusted earnings rose 21% on a reported basis and 25% on a constant-currency basis to $420 million. Sales increased 17% on a constant-currency basis, supported by Korea and product launches. In Japan, sales rose 2% from a strong year-earlier comparison and 13% sequentially, while accident and health sales grew nearly 90% on a constant-currency basis following a medical product launch.
Latin America posted a quarterly record of $268 million in adjusted earnings, up 15% reported and 4% on a constant-currency basis. Sales rose 9% on the same basis, with growth led by Brazil, Mexico and Chile. EMEA adjusted earnings increased 8%, or 11% on a constant-currency basis, to $108 million, while sales rose 15% on a constant-currency basis.
MetLife Investment Management, or MIM, generated adjusted earnings of $57 million, up 6%, as PineBridge integration and expense management contributed to results. Total assets under management rose $12 billion sequentially to approximately $748 billion at June 30, including a $7 billion increase in institutional client assets. McCallion said MIM remains positioned to deliver full-year adjusted earnings within its $240 million to $280 million guidance range, though likely near the low end.
M&A and Investment Positioning During the question-and-answer session, Khalaf said MetLife’s approach to acquisitions has not changed. He identified asset management and Group Benefits as the areas most likely to be considered for acquisitions, emphasizing complementary capabilities and adjacencies rather than transformational transactions.
McCallion said MetLife expects its private-equity allocation to decline modestly over time as distributions from its seasoned portfolio outpace contributions, though the company will continue investing in the asset class. He said higher interest rates can provide positive momentum over time, but portfolio changes are incremental and governed by asset-liability management and risk considerations.
About MetLife (NYSE:MET)MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Should You Invest $1,000 in MetLife Right Now?Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
For the quarter ended June 2026, MetLife (MET - Free Report) reported revenue of $19.08 billion, up 6.4% over the same period last year. EPS came in at $2.43, compared to $2.02 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $19.34 billion, representing a surprise of -1.38%. The company delivered an EPS surprise of +5.65%, with the consensus EPS estimate being $2.30.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how MetLife performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Institutional Client AUM: $320.46 billion versus $346.62 billion estimated by three analysts on average.Total AUM: $748.13 billion compared to the $741.21 billion average estimate based on three analysts.METLIFE INVESTMENT MANAGEMENT(MIM)-GA AUM: $427.67 billion compared to the $394.59 billion average estimate based on three analysts.Adjusted Revenue- Corporate & other- Net investment income: $944 million versus the three-analyst average estimate of $974.37 million. The reported number represents a year-over-year change of +1309%.Adjusted Revenue- Corporate & other- Premiums: $596 million compared to the $637.33 million average estimate based on three analysts. The reported number represents a change of +7350% year over year.Adjusted Revenue- EMEA- Net investment income: $67 million versus the three-analyst average estimate of $67.41 million. The reported number represents a year-over-year change of +9.8%.Adjusted Revenue- Latin America- Net investment income: $587 million versus $440.74 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +31.9% change.Revenue- Premiums: $11.44 billion versus $11.97 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +5.8% change.Revenue- Other Revenues: $845 million compared to the $742.31 million average estimate based on four analysts. The reported number represents a change of +24.5% year over year.Revenue- Net investment income: $6.7 billion versus $5.5 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +18.4% change.Revenue- Universal life and investment-type product policy fees: $1.37 billion versus $1.32 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +9% change.Adjusted Revenue- Retirement & Income Solutions- Premiums: $1.59 billion versus $2.03 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +31.2% change.View all Key Company Metrics for MetLife here>>>
Shares of MetLife have returned +4.9% over the past month versus the Zacks S&P 500 composite's +3.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
MetLife ve 2. čtvrtletí zvýšila upravený zisk díky silnému upisování a růstu objemu. Tržby z pojistného, poplatků a dalších výnosů vzrostly o 7 % na 13,7 miliardy USD.
The MetLife Inc building is seen in Manhattan, New York, U.S., December 7, 2021. REUTERS/Andrew Kelly Purchase Licensing Rights, opens new tab
CompaniesAug 5 (Reuters) - Life insurer MetLife (MET.N), opens new tab posted a jump in second-quarter adjusted profit on Wednesday, powered by strong underwriting and broad volume growth, with standout results in Asia and Latin America.
The industry has continued to benefit from resilient demand, robust sales growth and disciplined underwriting, while elevated interest rates have lifted investment returns.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
MetLife said premiums, fees and other revenue increased 7% in the second quarter to $13.7 billion.
This typically reflects the income insurers earn from selling insurance policies, annuities and related financial products.
Group benefits, which include employer-sponsored insurance products, posted a 25% increase in adjusted profit to $503 million.
Asia adjusted earnings grew 21% in the quarter, on a reported basis, while Latin America logged a 15% increase.
"This quarter further reinforces our ability to create value for shareholders across cycles," CEO Michel Khalaf said in a statement.
The company's second-quarter net investment income surged 18% to $6.7 billion.
Insurers typically generate investment income by investing premiums they collect, primarily in bonds and other low-risk assets.
MetLife said adjusted earnings per share rose 20% to $2.43 in the three months ended June 30.
Founded in 1868, MetLife operates in more than 40 markets and is one of the world's largest life insurers, offering insurance, annuities, employee benefits and asset management services to individuals and institutions.
Reporting by Manya Saini in Bengaluru; Editing by Sriraj Kalluvila
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Key Takeaways MET is expected to post Q2 EPS growth of 13.9% on 7.9% higher revenue year over year.MetLife may benefit from growth in Group Benefits and Retirement & Income Solutions results.MET's Q2 premiums are projected to increase 10.7% year over year. Insurance provider MetLife, Inc. (MET - Free Report) is set to report its second-quarter 2026 results on Aug. 5, 2026, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $2.30 per shareon revenues of $19.34 billion.
The second-quarter earnings estimate witnessed six upward revisions and no movement in the opposite direction over the past 60 days. The bottom-line projection indicates a year-over-year increase of 13.9%. Also, the Zacks Consensus Estimate for quarterly revenues suggests a year-over-year growth of 7.9%.
Image Source: Zacks Investment Research
For full-year 2026, the Zacks Consensus Estimate for MetLife’s revenues is pegged at $79.33 billion, implying a decline of 0.6% year over year. However, the consensus mark for 2026 EPS is pegged at $9.89, implying 12% year-over-year growth.
MetLife beat earnings estimates in three of the past four quarters and missed once, with the average surprise being 2.4%. This is depicted in the figure below.
Q2 Earnings Whispers for MetLifeOur proven model predicts a likely earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is precisely the case here.
MET has an Earnings ESP of +0.66% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
You can see the complete list of today’s Zacks #1 Rank stocks here.
What’s Shaping MetLife’s Q2 Results?The Zacks Consensus Estimate for second-quarter premiums indicates a 10.7% year-over-year increase. While the consensus mark signals 3.3% growth in Group Benefits adjusted revenues, the same from Retirement & Income Solutions is projected to jump 28% in the second quarter.
The consensus estimate indicates a 10.3% year-over-year increase in adjusted earnings from the Retirement & Income Solutions segment and 7.9% growth in adjusted earnings from the Group Benefits unit. MetLife Investment Management’s adjusted earnings are pegged at $60.7 million. Further, adjusted earnings from Asia are expected to grow 14.1% year over year and 3.4% from the Latin America business.
These are likely to have positioned the company for year-over-year growth and an earnings beat. The positives are likely to be partially offset by a 2.8% decline in net investment income. Also, adjusted earnings from the EMEA region are expected to decline 6.3% year over year.
How Did Other Insurers Fare This Quarter?Several insurance companies, including Marsh & McLennan Companies, Inc. (MRSH - Free Report) , AMERISAFE, Inc. (AMSF - Free Report) and RenaissanceRe Holdings Ltd. (RNR - Free Report) , have already reported their financial results for the June quarter of 2026. Here’s how they performed:
Marsh reported second-quarter 2026 adjusted earnings per share of $2.96, which surpassed the Zacks Consensus Estimate by 2.8%. The bottom line advanced 8.8% year over year.Its strong quarterly results benefited from solid growth in the Risk and Insurance Services and Consulting units. However, the upside was partially offset by Marsh’s elevated operating expenses, primarily due to increased compensation and benefits.
AMERISAFE reported second-quarter adjusted earnings per share of 44 cents, missing the Zacks Consensus Estimate by 17%. The bottom line also declined 17% year over year. The quarterly result was affected by higher expenses and weaker underwriting margins, with additional pressure from lower investment income. AMSF’s strong premium growth partly offset these headwinds.
RenaissanceRe reported second-quarter 2026 operating income of $12.92 per share, which surpassed the Zacks Consensus Estimate by 12.9%. The bottom line also improved 5.1% year over year. The quarterly earnings benefited from lower expenses, higher net investment income and an improved total combined ratio. However, the upside was partly offset by lower net premiums earned, weaker underwriting results in RNR’s Casualty & Specialty segment and lower fee income.
MetLife zavádí AI napříč klíčovými operacemi a za posledních pět let investovala do technologií více než 3,2 miliardy USD. V 1. čtvrtletí 2026 jí upravený zisk na akcii (EPS) meziročně vzrostl o 23,5 % na 2,42 USD.
Key Takeaways MetLife is embedding AI across core operations to improve efficiency and customer experiences.MET invested $3.2 billion in technology over five years to support enterprise-wide AI adoption.MET's Q1 2026 adjusted EPS rose 23.5% YoY, while its direct expense ratio improved to 11.9%. MetLife, Inc. (MET - Free Report) is increasingly embedding artificial intelligence (AI) across its business as part of its New Frontier strategy, with the goal of improving efficiency, enhancing customer experiences and supporting long-term growth. Rather than treating AI as a standalone initiative, the insurer is integrating the technology into core operations, from underwriting and claims to customer service and decision-making. This approach is helping the company simplify workflows while positioning it to compete more effectively in an evolving insurance market.
MetLife has invested more than $3.2 billion over the past five years to modernize its technology infrastructure. These investments are enabling broader AI adoption across the enterprise. AI tools are helping employees make faster decisions, reduce operational friction and deliver more personalized customer interactions. MetLife continues to emphasize responsible AI deployment through robust governance and risk management practices.
The company's AI investments are already supporting stronger operating performance. In the first quarter of 2026, adjusted earnings per share (EPS) increased 23.5% year over year to $2.42. At the same time, MetLife's direct expense ratio, excluding total notable items related to direct expenses and PRT, improved to 11.9% from 12% a year ago, reflecting continued productivity gains and disciplined cost management.
AI is becoming more than an operational tool for MetLife — it is evolving into a strategic differentiator. By combining technology-driven efficiency with disciplined execution and a diversified business model, the company is positioning itself to improve productivity, strengthen customer relationships and build a sustainable competitive advantage over the long run.
How Are Competitors Faring?Some of MET’s competitors adopting AI to improve operations include American International Group, Inc. (AIG - Free Report) and CNO Financial Group, Inc. (CNO - Free Report) .
AIG is expanding its use of AI to improve underwriting accuracy, automate claims handling and strengthen risk assessment. American International Group is also using generative AI to support employees and streamline workflows, helping improve operational efficiency while delivering faster and more personalized customer service.
CNO Financial is adopting AI and advanced analytics to modernize customer engagement, automate routine processes and improve agent productivity. CNO is also investing in digital capabilities that simplify policy servicing and support more personalized insurance solutions, strengthening its long-term operating efficiency.
MET’s Price Performance, Valuation & EstimatesIn the year-to-date period, MET’s shares have risen 17.3% compared with the industry’s growth of 4.9%.
Image Source: Zacks Investment Research
From a valuation standpoint, MET trades at a forward price-to-earnings ratio of 8.80, above the industry average of 8.27. MetLife carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MET’s 2026 earnings implies 13% growth from the year-ago period.
Image Source: Zacks Investment Research
MetLife currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
